ArticleInternational journal of molecular sciences2022

Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection.

Damiana-Maria Vulturar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.